Patient | (n = 41) | (%) |
---|---|---|
Age | 45–73 years (mean, 58.56 ± 9.40 years) | |
Gender | ||
Male | 35 | 85.4 |
Female | 6 | 14.6 |
Familial CAD history | 18 | 43.9 |
Hypertension | 37 | 90.2 |
Diabetes mellitus | 18 | 43.9 |
Obesity | 29 | 70.7 |
Dyslipidemia | 33 | 80.5 |
Smoking | 27 | 65.9 |
Hyperuricemia | 0 | 0 |
β-Blocker usage | 35 | 85.4 |
Statin usage | 13 | 31.7 |
Stable angina Pectoris | 6 | 14.6 |
Unstable angina Pectoris | 26 | 63.4 |
Acute myocardial infarction | 9 | 22 |
PAD | 3 | 7.3 |
COPD | 13 | 31.7 |
NYHA CLASS I | 2 | 4.9 |
NYHA CLASS II | 30 | 73.2 |
NYHA CLASS III | 9 | 22 |
CAG (diseased vessels) | ||
LMCA | 4 | 9.8 |
LMCA + 3 vessels | 2 | 4.9 |
3 vessels | 22 | 53.9 |
2 vessels | 16 | 39.2 |
1 vessel | 0 | 0 |
Microvascular area disease | 1 | 2.45 |
LVEF (%) | ||
Low (<30%) | 0 | 0 |
Intermediate (30–45%) | 7 | 17.1 |
High (>45%) | 34 | 82.9 |
Diastolic dysfunction | ||
Grade 1 | 8 | 19.5 |
Grade 2 | 33 | 80.5 |